CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus 中国心力衰竭诊断和治疗指南2018 Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart Failure Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial

Original Research2018 Jun 5;71(22):2497-2506.

JOURNAL:J Am Coll Cardiol. Article Link

SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL

Cavender MA, Norhammar A, CVD-REAL Investigators and Study Group. Keywords: CVD-REAL; cardiovascular disease; heart failure; sodium-glucose co-transporter-2 inhibitors

FULL TEXT PDF